TREA

86843003 - DERMASEQ

Follow

Information

  • Trademark
  • 86843003
  • Serial Number
    86843003
  • Filing Date
    December 08, 2015
    9 years ago
  • Transaction Date
    February 14, 2018
    6 years ago
  • Status Date
    September 27, 2016
    8 years ago
  • Location Date
    September 27, 2016
    8 years ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    SCHRODY, ALLISON PAIGE
  • Attorney Docket Number
    10214-00502-
    Attorney Name
    Hoang-chi Truong
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
DERMASEQ
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • DM0000: The mark consists of The mark consists of the word "dermaSEQ," with the term "derma" in lower case and the term "SEQ" in uppercase and the "Q" in "SEQ" is meant to appear as a magnifying glass and has a glint/reflection mark inside the letter.
  • GS0421: Medical and scientific research in the fields of cutaneous T-cell lymphoma and skin-related cancers and diagnosing and treating same; scientific research, development, engineering, testing, and analytical services for diagnosing and treating cutaneous T-cell lymphoma and skin-related cancers; providing diagnostic assays and diagnostic or prognostic testing for diagnosing cutaneous T-cell lymphoma and skin-related cancers; providing analysis, evaluation, and clinical reports of a patient's condition with regard to cutaneous T-cell lymphoma and skin-related cancers; providing diagnostic assays and diagnostic or prognostic testing for cutaneous T-cell lymphoma and skin-related cancers, and the analysis, evaluation, and reports of those test results to help healthcare professionals determine a patient's diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly; research and development of diagnostic test kits for detecting and diagnosing cutaneous T-cell lymphoma and skin-related cancers; laboratory research and testing services relating to detecting and diagnosing cutaneous T-cell lymphoma and skin-related cancers; computer services, namely, software as a service (SAAS) services featuring software that provides information, test results for detecting and diagnosing cutaneous T-cell lymphoma and skin-related cancers, and the analysis, evaluation, and reporting of those test results to healthcare professionals to determine a patient's clinical diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly
  • GS0441: Medical services; medical analysis and diagnostic services; medical diagnostic services, namely, medical testing for diagnostic or treatment purposes; medical diagnostic services, namely, medical diagnostic testing, monitoring and reporting services; providing medical diagnostic testing for the detection, diagnosis, and treatment of cutaneous T-cell lymphoma and skin-related cancers; providing medical testing for immune responses to immunotherapy or cancer treatment
  • PM0001: DERMA SEQ
Case File Event Statements
  • 2/13/2018 - 6 years ago
    10 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/27/2016 - 8 years ago
    9 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 9/27/2016 - 8 years ago
    8 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 3/25/2016 - 8 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/25/2016 - 8 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/25/2016 - 8 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/24/2016 - 8 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/12/2015 - 9 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM
  • 12/11/2015 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 12/11/2015 - 9 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP